Adjuvant Therapy Use for Patients With Inadequately Resected T1b-T3 Gallbladder Cancer.
McKenzie J WhiteSaranya PrathibhaArjun GuptaAjay PrakashJacob S AnkenyChristopher J LaRoccaJane Y C HuiTodd M TuttleDavid BrauerSchelomo MarmorEric H Jensen
Published in: The Journal of surgical research (2024)
AT was associated with prolonged OS for patients with inadequately resected T1b-T3 GBC. CRT may have a role in treatment for patients with high-risk disease following inadequate resection of T1b-T3 GBC.